Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia
We assessed the performance of 3 validated prognostic rules in predicting 30-day mortality in community-acquired pneumonia: the 20 variable Pneumonia Severity Index and the easier to calculate CURB (confusion, urea nitrogen, respiratory rate, blood pressure) and CURB-65 severity scores. We prospecti...
Saved in:
| Published in | The American journal of medicine Vol. 118; no. 4; pp. 384 - 392 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.04.2005
Elsevier Sequoia S.A |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0002-9343 1555-7162 |
| DOI | 10.1016/j.amjmed.2005.01.006 |
Cover
| Abstract | We assessed the performance of 3 validated prognostic rules in predicting 30-day mortality in community-acquired pneumonia: the 20 variable Pneumonia Severity Index and the easier to calculate CURB (confusion, urea nitrogen, respiratory rate, blood pressure) and CURB-65 severity scores.
We prospectively followed 3181 patients with community-acquired pneumonia from 32 hospital emergency departments (January–December 2001) and assessed mortality 30 days after initial presentation. Patients were stratified into Pneumonia Severity Index risk classes (I–V) and CURB (0–4) and CURB-65 (0–5) risk strata. We compared the discriminatory power (area under the receiver operating characteristic curve) of these rules to predict mortality and their accuracy based on sensitivity, specificity, predictive values, and likelihood ratios.
The Pneumonia Severity Index (risk classes I–III) classified a greater proportion of patients as low risk (68% [2152/3181]) than either a CURB score <1 (51% [1635/3181]) or a CURB-65 score <2 (61% [1952/3181]). Low-risk patients identified based on the Pneumonia Severity Index had a slightly lower mortality (1.4% [31/2152]) than patients classified as low-risk based on the CURB (1.7% [28/1635]) or the CURB-65 (1.7% [33/1952]). The area under the receiver operating characteristic curve was higher for the Pneumonia Severity Index (0.81) than for either the CURB (0.73) or CURB-65 (0.76) scores (
P <0.001, for each pairwise comparison). At comparable cut-points, the Pneumonia Severity Index had a higher sensitivity and a somewhat higher negative predictive value for mortality than either CURB score.
The more complex Pneumonia Severity Index has a higher disciminatory power for short-term mortality, defines a greater proportion of patients at low risk, and is slightly more accurate in identifying patients at low risk than either CURB score. |
|---|---|
| AbstractList | We assessed the performance of 3 validated prognostic rules in predicting 30-day mortality in community-acquired pneumonia: the 20 variable Pneumonia Severity Index and the easier to calculate CURB (confusion, urea nitrogen, respiratory rate, blood pressure) and CURB-65 severity scores.
We prospectively followed 3181 patients with community-acquired pneumonia from 32 hospital emergency departments (January–December 2001) and assessed mortality 30 days after initial presentation. Patients were stratified into Pneumonia Severity Index risk classes (I–V) and CURB (0–4) and CURB-65 (0–5) risk strata. We compared the discriminatory power (area under the receiver operating characteristic curve) of these rules to predict mortality and their accuracy based on sensitivity, specificity, predictive values, and likelihood ratios.
The Pneumonia Severity Index (risk classes I–III) classified a greater proportion of patients as low risk (68% [2152/3181]) than either a CURB score <1 (51% [1635/3181]) or a CURB-65 score <2 (61% [1952/3181]). Low-risk patients identified based on the Pneumonia Severity Index had a slightly lower mortality (1.4% [31/2152]) than patients classified as low-risk based on the CURB (1.7% [28/1635]) or the CURB-65 (1.7% [33/1952]). The area under the receiver operating characteristic curve was higher for the Pneumonia Severity Index (0.81) than for either the CURB (0.73) or CURB-65 (0.76) scores (
P <0.001, for each pairwise comparison). At comparable cut-points, the Pneumonia Severity Index had a higher sensitivity and a somewhat higher negative predictive value for mortality than either CURB score.
The more complex Pneumonia Severity Index has a higher disciminatory power for short-term mortality, defines a greater proportion of patients at low risk, and is slightly more accurate in identifying patients at low risk than either CURB score. We assessed the performance of 3 validated prognostic rules in predicting 30-day mortality in community-acquired pneumonia: the 20 variable Pneumonia Severity Index and the easier to calculate CURB (confusion, urea nitrogen, respiratory rate, blood pressure) and CURB-65 severity scores. We prospectively followed 3181 patients with community-acquired pneumonia from 32 hospital emergency departments (January-December 2001) and assessed mortality 30 days after initial presentation. Patients were stratified into Pneumonia Severity Index risk classes (I-V) and CURB (0-4) and CURB-65 (0-5) risk strata. We compared the discriminatory power (area under the receiver operating characteristic curve) of these rules to predict mortality and their accuracy based on sensitivity, specificity, predictive values, and likelihood ratios. The Pneumonia Severity Index (risk classes I-III) classified a greater proportion of patients as low risk (68% [2152/3181]) than either a CURB score <1 (51% [1635/3181]) or a CURB-65 score <2 (61% [1952/3181]). Low-risk patients identified based on the Pneumonia Severity Index had a slightly lower mortality (1.4% [31/2152]) than patients classified as low-risk based on the CURB (1.7% [28/1635]) or the CURB-65 (1.7% [33/1952]). The area under the receiver operating characteristic curve was higher for the Pneumonia Severity Index (0.81) than for either the CURB (0.73) or CURB-65 (0.76) scores (P <0.001, for each pairwise comparison). At comparable cut-points, the Pneumonia Severity Index had a higher sensitivity and a somewhat higher negative predictive value for mortality than either CURB score. The more complex Pneumonia Severity Index has a higher discriminatory power for short-term mortality, defines a greater proportion of patients at low risk, and is slightly more accurate in identifying patients at low risk than either CURB score. We assessed the performance of 3 validated prognostic rules in predicting 30-day mortality in community-acquired pneumonia: the 20 variable Pneumonia Severity Index and the easier to calculate CURB (confusion, urea nitrogen, respiratory rate, blood pressure) and CURB-65 severity scores.PURPOSEWe assessed the performance of 3 validated prognostic rules in predicting 30-day mortality in community-acquired pneumonia: the 20 variable Pneumonia Severity Index and the easier to calculate CURB (confusion, urea nitrogen, respiratory rate, blood pressure) and CURB-65 severity scores.We prospectively followed 3181 patients with community-acquired pneumonia from 32 hospital emergency departments (January-December 2001) and assessed mortality 30 days after initial presentation. Patients were stratified into Pneumonia Severity Index risk classes (I-V) and CURB (0-4) and CURB-65 (0-5) risk strata. We compared the discriminatory power (area under the receiver operating characteristic curve) of these rules to predict mortality and their accuracy based on sensitivity, specificity, predictive values, and likelihood ratios.SUBJECTS AND METHODSWe prospectively followed 3181 patients with community-acquired pneumonia from 32 hospital emergency departments (January-December 2001) and assessed mortality 30 days after initial presentation. Patients were stratified into Pneumonia Severity Index risk classes (I-V) and CURB (0-4) and CURB-65 (0-5) risk strata. We compared the discriminatory power (area under the receiver operating characteristic curve) of these rules to predict mortality and their accuracy based on sensitivity, specificity, predictive values, and likelihood ratios.The Pneumonia Severity Index (risk classes I-III) classified a greater proportion of patients as low risk (68% [2152/3181]) than either a CURB score <1 (51% [1635/3181]) or a CURB-65 score <2 (61% [1952/3181]). Low-risk patients identified based on the Pneumonia Severity Index had a slightly lower mortality (1.4% [31/2152]) than patients classified as low-risk based on the CURB (1.7% [28/1635]) or the CURB-65 (1.7% [33/1952]). The area under the receiver operating characteristic curve was higher for the Pneumonia Severity Index (0.81) than for either the CURB (0.73) or CURB-65 (0.76) scores (P <0.001, for each pairwise comparison). At comparable cut-points, the Pneumonia Severity Index had a higher sensitivity and a somewhat higher negative predictive value for mortality than either CURB score.RESULTSThe Pneumonia Severity Index (risk classes I-III) classified a greater proportion of patients as low risk (68% [2152/3181]) than either a CURB score <1 (51% [1635/3181]) or a CURB-65 score <2 (61% [1952/3181]). Low-risk patients identified based on the Pneumonia Severity Index had a slightly lower mortality (1.4% [31/2152]) than patients classified as low-risk based on the CURB (1.7% [28/1635]) or the CURB-65 (1.7% [33/1952]). The area under the receiver operating characteristic curve was higher for the Pneumonia Severity Index (0.81) than for either the CURB (0.73) or CURB-65 (0.76) scores (P <0.001, for each pairwise comparison). At comparable cut-points, the Pneumonia Severity Index had a higher sensitivity and a somewhat higher negative predictive value for mortality than either CURB score.The more complex Pneumonia Severity Index has a higher discriminatory power for short-term mortality, defines a greater proportion of patients at low risk, and is slightly more accurate in identifying patients at low risk than either CURB score.CONCLUSIONSThe more complex Pneumonia Severity Index has a higher discriminatory power for short-term mortality, defines a greater proportion of patients at low risk, and is slightly more accurate in identifying patients at low risk than either CURB score. Purpose: We assessed the performance of 3 validated prognostic rules in predicting 30-day mortality in community-acquired pneumonia: the 20 variable Pneumonia Severity Index and the easier to calculate CURB (confusion, urea nitrogen, respiratory rate, blood pressure) and CURB-65 severity scores. Subjects and methods: We prospectively followed 3,181 patients with community-acquired pneumonia from 32 hospital emergency departments (January-December 2001) and assessed mortality 30 days after initial presentation. Patients were stratified into Pneumonia Severity Index risk classes (I-V) and CURB (0-4) and CURB-65 (0-5) risk strata. We compared the discriminatory power (area under the receiver operating characteristic curve) of these rules to predict mortality and their accuracy based on sensitivity, specificity, predictive values, and likelihood ratios. Results: The Pneumonia Severity Index (risk classes I-III) classified a greater proportion of patients as low risk (68% [2152/3181]) than either a CURB score <1 (51% [1635/3181]) or a CURB-65 score <2 (61% [1952/3181]). Low-risk patients identified based on the Pneumonia Severity Index had a slightly lower mortality (1.4% [31/2152]) than patients classified as low-risk based on the CURB (1.7% [28/1635]) or the CURB-65 (1.7% [33/1952]). The area under the receiver operating characteristic curve was higher for the Pneumonia Severity Index (0.81) than for either the CURB (0.73) or CURB-65 (0.76) scores (P <0.001, for each pairwise comparison). At comparable cut-points, the Pneumonia Severity Index had a higher sensitivity and a somewhat higher negative predictive value for mortality than either CURB score. Conclusions: The more complex Pneumonia Severity Index has a higher disciminatory power for short-term mortality, defines a greater proportion of patients at low risk, and is slightly more accurate in identifying patients at low risk than either CURB score. [PUBLICATION ABSTRACT] |
| Author | Aujesky, Drahomir Fine, Jonathan M. Fine, Michael J. Obrosky, D. Scott Auble, Thomas E. Stone, Roslyn A. Meehan, Thomas P. Yealy, Donald M. Graff, Louis G. |
| Author_xml | – sequence: 1 givenname: Drahomir surname: Aujesky fullname: Aujesky, Drahomir email: aujesky@swissonline.ch organization: Division of General Internal Medicine, Department of Medicine – sequence: 2 givenname: Thomas E. surname: Auble fullname: Auble, Thomas E. organization: Department of Emergency Medicine – sequence: 3 givenname: Donald M. surname: Yealy fullname: Yealy, Donald M. organization: Department of Emergency Medicine – sequence: 4 givenname: Roslyn A. surname: Stone fullname: Stone, Roslyn A. organization: Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh – sequence: 5 givenname: D. Scott surname: Obrosky fullname: Obrosky, D. Scott organization: Division of General Internal Medicine, Department of Medicine – sequence: 6 givenname: Thomas P. surname: Meehan fullname: Meehan, Thomas P. organization: Qualidigm – sequence: 7 givenname: Louis G. surname: Graff fullname: Graff, Louis G. organization: Qualidigm – sequence: 8 givenname: Jonathan M. surname: Fine fullname: Fine, Jonathan M. organization: Section of Pulmonary and Critical Care Medicine, Norwalk Hospital – sequence: 9 givenname: Michael J. surname: Fine fullname: Fine, Michael J. organization: Division of General Internal Medicine, Department of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15808136$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkcFq3DAURUVIaSZp_yAE00V3dp8kS7ZDCZTQtIVAu2jXQpbfJHJsaSLZA_P3lZkki1kkK2H5nIu495QcO--QkHMKBQUqv_SFHvsRu4IBiAJoASCPyIoKIfKKSnZMVgDA8oaX_IScxtinT2iEfE9OqKihplyuyP2f4OMGzWS3mBk_bnSw0bvMr7PpPiBmWz3YTk_YZZuAnU1g-hvmAWO29iFd-jvno42ZdYs_zs5Ou1ybx9mGRXI4j95Z_YG8W-sh4sen84z8u_n-9_pnfvv7x6_rb7e5ESCnvGFNbQSTsu04gAEu60rrksuSUkSjmRDAsGZt05a0kQCVROCJbStGdc34Gfm8z00ve5wxTmq00eAwaId-jkpWFTCQkMBPB2Dv5-DS2xTjjHNK2ZJ28QTNbepabYIdddip5wITcLkHTOoxBlwrYye9lDQFbQdFQS1rqV7t11LLWgqoSmsluTyQX_Jf1672GqYetxaDisaiM2mekJZUnbdvBXw9CDCDddbo4QF3b-v_AbCDxI0 |
| CODEN | AJMEAZ |
| CitedBy_id | crossref_primary_10_1016_j_mcna_2024_12_011 crossref_primary_10_1155_2022_6391141 crossref_primary_10_1016_S0761_8425_06_77732_4 crossref_primary_10_1016_j_ejim_2020_04_055 crossref_primary_10_1016_j_mcna_2011_08_007 crossref_primary_10_1017_S0950268820002368 crossref_primary_10_1183_09031936_06_00130305 crossref_primary_10_1183_23120541_00051_2023 crossref_primary_10_7326_AITC202204190 crossref_primary_10_2298_VSP1005364D crossref_primary_10_1016_j_arbres_2017_01_013 crossref_primary_10_1097_JMQ_0000000000000042 crossref_primary_10_2169_internalmedicine_45_1691 crossref_primary_10_38053_acmj_801894 crossref_primary_10_1038_s41598_024_65488_1 crossref_primary_10_1007_s11739_020_02483_0 crossref_primary_10_1111_imj_12795 crossref_primary_10_1177_2010105815623292 crossref_primary_10_1097_MLR_0000000000000989 crossref_primary_10_1086_591394 crossref_primary_10_1016_j_acci_2023_12_009 crossref_primary_10_1007_s00391_015_0896_x crossref_primary_10_1371_journal_pone_0197418 crossref_primary_10_1016_S0246_0289_08_44773_4 crossref_primary_10_1097_QCO_0b013e3280106b7f crossref_primary_10_1111_j_1445_5994_2007_01455_x crossref_primary_10_1007_s00134_010_1818_4 crossref_primary_10_1016_j_rmed_2009_06_013 crossref_primary_10_7883_yoken_JJID_2018_187 crossref_primary_10_1378_chest_129_4_968 crossref_primary_10_23736_S2532_1285_23_00172_6 crossref_primary_10_5694_j_1326_5377_2010_tb03450_x crossref_primary_10_1111_apt_12532 crossref_primary_10_18231_j_ijca_2024_036 crossref_primary_10_7326_AITC201510060 crossref_primary_10_7883_yoken_66_359 crossref_primary_10_3947_ic_2009_41_3_133 crossref_primary_10_1016_j_annemergmed_2011_12_010 crossref_primary_10_1007_s10096_014_2234_4 crossref_primary_10_1007_s11739_022_02999_7 crossref_primary_10_1016_j_diagmicrobio_2010_01_005 crossref_primary_10_1183_09031936_06_00130205 crossref_primary_10_1016_j_jcrc_2010_07_002 crossref_primary_10_1378_chest_10_1296 crossref_primary_10_1016_j_arbres_2010_06_014 crossref_primary_10_1111_j_1553_2712_2012_01424_x crossref_primary_10_1016_j_annemergmed_2008_01_010 crossref_primary_10_7759_cureus_36052 crossref_primary_10_1016_j_rppnen_2013_10_001 crossref_primary_10_1016_j_aprim_2012_12_005 crossref_primary_10_1016_j_clnesp_2021_06_021 crossref_primary_10_1016_j_measurement_2012_02_006 crossref_primary_10_1016_j_jiph_2022_10_015 crossref_primary_10_15446_revfacmed_v70n2_93814 crossref_primary_10_1093_ageing_afs158 crossref_primary_10_1111_j_1445_5994_2009_02062_x crossref_primary_10_1111_j_1440_1843_2012_02275_x crossref_primary_10_1016_j_rmr_2010_08_010 crossref_primary_10_1080_00365540701663381 crossref_primary_10_4103_ejcdt_ejcdt_139_20 crossref_primary_10_1017_S0950268808000435 crossref_primary_10_1097_SHK_0000000000002149 crossref_primary_10_1080_17476348_2025_2464880 crossref_primary_10_1007_s40271_013_0013_4 crossref_primary_10_1086_511159 crossref_primary_10_2169_internalmedicine_50_4651 crossref_primary_10_4103_jfmpc_jfmpc_85_22 crossref_primary_10_1016_j_medcli_2009_09_049 crossref_primary_10_1086_501354 crossref_primary_10_1111_crj_12560 crossref_primary_10_1016_j_rmed_2010_05_022 crossref_primary_10_1186_s12911_024_02523_1 crossref_primary_10_1016_j_annemergmed_2008_01_003 crossref_primary_10_21320_1818_474X_2018_4_30_37 crossref_primary_10_7759_cureus_46893 crossref_primary_10_1016_j_gie_2015_10_021 crossref_primary_10_1016_j_jinf_2010_03_021 crossref_primary_10_1186_s12877_024_05270_0 crossref_primary_10_5005_ijcdas_52_1_9 crossref_primary_10_1016_j_ajem_2008_07_037 crossref_primary_10_1097_MCP_0b013e3280f6cf02 crossref_primary_10_1093_cid_cis970 crossref_primary_10_1080_17512433_2017_1268051 crossref_primary_10_7570_jomes20121 crossref_primary_10_4046_trd_2009_67_4_281 crossref_primary_10_1002_jhm_2190 crossref_primary_10_1016_j_suc_2014_09_001 crossref_primary_10_1016_j_jinf_2010_08_006 crossref_primary_10_1007_BF03086723 crossref_primary_10_1111_j_1742_6723_2007_01003_x crossref_primary_10_1016_S0929_6646_09_60055_3 crossref_primary_10_1093_cid_cir531 crossref_primary_10_1111_j_1440_1843_2008_01329_x crossref_primary_10_1016_j_cpha_2016_12_001 crossref_primary_10_1016_S1280_4703_17_86784_0 crossref_primary_10_1007_s10096_011_1272_4 crossref_primary_10_1093_qjmed_hcp027 crossref_primary_10_1111_j_1445_5994_2007_01548_x crossref_primary_10_1177_0885066610383949 crossref_primary_10_5124_jkma_2007_50_10_868 crossref_primary_10_1111_imj_15534 crossref_primary_10_1007_s00134_007_0982_7 crossref_primary_10_1016_j_fmc_2020_01_004 crossref_primary_10_1016_j_annemergmed_2020_10_024 crossref_primary_10_1097_MCC_0000000000001189 crossref_primary_10_1590_1806_9282_61_02_144 crossref_primary_10_1093_jac_dkq426 crossref_primary_10_1016_j_medcli_2012_09_034 crossref_primary_10_1111_irv_12174 crossref_primary_10_1177_1753465810381518 crossref_primary_10_1111_acem_14655 crossref_primary_10_1183_09031936_00065610 crossref_primary_10_1016_S1579_2129_11_60008_6 crossref_primary_10_3390_medicina57020179 crossref_primary_10_1016_j_medmal_2006_07_011 crossref_primary_10_1136_bmjresp_2024_002289 crossref_primary_10_1183_09031936_00172910 crossref_primary_10_4028_www_scientific_net_AMM_783_29 crossref_primary_10_1109_ACCESS_2020_2969482 crossref_primary_10_1111_imj_12374 crossref_primary_10_1097_IPC_0000000000000862 crossref_primary_10_1016_j_rmed_2011_06_010 crossref_primary_10_1002_msj_20066 crossref_primary_10_17795_iji_36409 crossref_primary_10_2217_1745509X_2_6_999 crossref_primary_10_1007_s10096_012_1693_8 crossref_primary_10_5694_j_1326_5377_2006_tb00496_x crossref_primary_10_35366_115676 crossref_primary_10_1016_S1286_9341_20_43271_5 crossref_primary_10_1186_cc7781 crossref_primary_10_1016_j_rppneu_2012_09_006 crossref_primary_10_1016_j_jemermed_2017_05_035 crossref_primary_10_1016_j_ejim_2006_10_003 crossref_primary_10_1097_QCO_0b013e328014da75 crossref_primary_10_1016_S1280_4703_09_70459_1 crossref_primary_10_1136_bmjresp_2014_000038 crossref_primary_10_14260_jemds_2017_1408 crossref_primary_10_1016_j_cyto_2007_05_002 crossref_primary_10_1016_j_ccm_2007_08_004 crossref_primary_10_2147_DMSO_S303124 crossref_primary_10_1097_QCO_0b013e3283368333 crossref_primary_10_11622_smedj_2017079 crossref_primary_10_1007_s11908_008_0036_5 crossref_primary_10_1086_593195 crossref_primary_10_1164_rccm_201908_1581ST crossref_primary_10_7759_cureus_41975 crossref_primary_10_1016_j_ejim_2012_04_016 crossref_primary_10_1016_j_annemergmed_2009_07_002 crossref_primary_10_1111_j_1742_1241_2009_02147_x crossref_primary_10_36106_gjra_0117049 crossref_primary_10_1016_j_arbr_2017_01_026 crossref_primary_10_1111_acem_13306 crossref_primary_10_1371_journal_pone_0087382 crossref_primary_10_1177_0272989X10386232 crossref_primary_10_1159_000508666 crossref_primary_10_1016_j_idc_2007_10_003 crossref_primary_10_1016_j_ijmedinf_2022_104778 crossref_primary_10_1111_j_1469_0691_2007_01772_x crossref_primary_10_12687_phleb2251_4_2015 crossref_primary_10_2147_CLEP_S359072 crossref_primary_10_1086_509331 crossref_primary_10_1093_ageing_afp164 crossref_primary_10_1038_s41598_023_50970_z crossref_primary_10_5694_j_1326_5377_2006_tb00162_x crossref_primary_10_1038_ki_2009_502 crossref_primary_10_1016_j_jinf_2009_11_013 crossref_primary_10_1186_1471_2466_8_16 crossref_primary_10_3389_fimmu_2021_707159 crossref_primary_10_1016_j_eimc_2012_04_012 crossref_primary_10_1016_j_ccm_2011_05_001 crossref_primary_10_1016_j_jemermed_2019_08_043 crossref_primary_10_1007_s11739_019_02243_9 crossref_primary_10_1378_chest_06_1994 crossref_primary_10_1007_s11908_011_0178_8 crossref_primary_10_1016_j_emc_2011_12_002 crossref_primary_10_1378_chest_08_2179 crossref_primary_10_7197_223_v39i31705_347458 crossref_primary_10_1586_17476348_2_2_261 crossref_primary_10_1016_j_ijantimicag_2020_106155 crossref_primary_10_1186_s12879_021_06388_x crossref_primary_10_2478_rjim_2021_0025 crossref_primary_10_1007_s00134_010_1986_2 crossref_primary_10_1016_j_rmed_2022_106884 crossref_primary_10_5124_jkma_2010_53_1_20 crossref_primary_10_1186_1471_2466_8_11 crossref_primary_10_1513_AnnalsATS_201512_848OC crossref_primary_10_1093_cid_ciaa860 crossref_primary_10_1111_j_1440_1843_2012_02183_x crossref_primary_10_1542_hpeds_2022_006539 crossref_primary_10_1016_S1283_0771_09_70288_9 crossref_primary_10_1093_jac_dkq038 crossref_primary_10_1111_j_1365_3156_2012_03006_x crossref_primary_10_1185_03007990903102743 crossref_primary_10_1111_j_1742_1241_2011_02742_x crossref_primary_10_1111_imj_15583 crossref_primary_10_15441_ceem_23_142 crossref_primary_10_3810_pgm_2005_10_1695 crossref_primary_10_1016_j_jen_2016_02_012 crossref_primary_10_3399_bjgp10X532422 crossref_primary_10_11622_smedj_2014082 crossref_primary_10_5694_j_1326_5377_2006_tb00163_x crossref_primary_10_1111_j_1440_1843_2009_01494_x crossref_primary_10_3143_geriatrics_44_483 crossref_primary_10_1371_journal_pone_0188913 crossref_primary_10_1586_17476348_2016_1144477 crossref_primary_10_1016_j_emc_2008_02_005 crossref_primary_10_1016_j_ejim_2011_10_002 crossref_primary_10_1016_j_cmi_2020_09_041 crossref_primary_10_1111_j_1469_0691_2009_02901_x crossref_primary_10_1183_09031936_06_00062505 crossref_primary_10_2169_internalmedicine_51_8159 crossref_primary_10_3947_ic_2018_50_2_160 crossref_primary_10_1016_j_ejcdt_2016_05_010 crossref_primary_10_1371_journal_pone_0082178 crossref_primary_10_12998_wjcc_v9_i13_2994 crossref_primary_10_1186_1471_2466_14_149 crossref_primary_10_1007_s13341_011_0057_9 crossref_primary_10_3109_00365548_2011_562529 crossref_primary_10_1097_IPC_0b013e318042e19a crossref_primary_10_4104_pcrj_2013_00034 crossref_primary_10_3390_app15063074 |
| Cites_doi | 10.1136/thx.2004.024992 10.1016/S0891-5520(05)70208-7 10.1016/S0149-2918(00)88483-0 10.1086/313954 10.1136/thx.2003.008110 10.1001/archinte.158.12.1350 10.1093/oxfordjournals.qjmed.a068093 10.1016/0002-9343(93)90177-Q 10.1067/mem.2001.115880 10.1001/jama.1996.03530260048030 10.1056/NEJM199701233360402 10.1164/ajrccm.163.7.at1010 10.1136/thx.51.10.1010 10.1055/s-2007-1021315 10.7326/0003-4819-138-2-200301210-00012 10.1136/thorax.58.5.377 10.1056/NEJMcp020499 10.1007/BF02295996 10.1148/radiology.143.1.7063747 10.1136/thorax.56.4.296 10.1046/j.1525-1497.2002.10750.x 10.1086/380488 10.1016/j.annemergmed.2003.09.013 10.1378/chest.124.1.121 |
| ContentType | Journal Article |
| Copyright | 2005 Elsevier Inc. Copyright Elsevier Sequoia S.A. Apr 2005 |
| Copyright_xml | – notice: 2005 Elsevier Inc. – notice: Copyright Elsevier Sequoia S.A. Apr 2005 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 7TK 7TO 7TS 7U9 H94 K9. 7X8 |
| DOI | 10.1016/j.amjmed.2005.01.006 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Neurosciences Abstracts Oncogenes and Growth Factors Abstracts Physical Education Index Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Neurosciences Abstracts Physical Education Index MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Virology and AIDS Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1555-7162 |
| EndPage | 392 |
| ExternalDocumentID | 820747161 15808136 10_1016_j_amjmed_2005_01_006 S0002934305000070 |
| Genre | Research Support, U.S. Gov't, P.H.S Comparative Study Research Support, Non-U.S. Gov't Journal Article Feature |
| GrantInformation_xml | – fundername: AHRQ HHS grantid: R01 HS 10049-03 |
| GroupedDBID | --- --K -~X .-4 .1- .55 .FO .GJ 0R~ 123 1B1 1CY 1P~ 1RT 1~5 23M 3O- 4.4 457 4CK 4G. 53G 5RE 5VS 6J9 7-5 AAEDT AAEDW AAFWJ AALRI AAQFI AAQQT AAQXK AAWTL AAXUO AAYWO ABLJU ABMAC ABOCM ABPPZ ABWVN ACGFO ACIUM ACKOT ACPRK ACRPL ACVFH ADBBV ADCNI ADMUD ADNMO ADVLN AENEX AEUPX AEVXI AFFNX AFHKK AFJKZ AFPUW AFRHN AFTJW AGHFR AGQPQ AHHHB AHMBA AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BELOY BKOMP C5W CS3 EBS EFJIC EFKBS EJD EX3 F5P FDB FEDTE FGOYB FIRID G-2 G-Q GBLVA HEA HMK HMO HVGLF HZ~ IH2 IHE J1W J5H K-O KOM L7B LZ2 M29 M41 MO0 MVM N4W N9A NQ- O9- OD. OHT OO~ P2P PC. PQQKQ R2- ROL RPZ SAE SEL SES SSZ TWZ UBY UHB UHU UNMZH UV1 WH7 WOW WUQ X7M XH2 XPP YFH YOC YQJ YYQ Z5R ZGI ZUP ZXP AACTN AAIAV AAYOK ADPAM AGZHU AHPSJ ALXNB NCXOZ RIG ZA5 AAYXX CITATION AFCTW CGR CUY CVF ECM EIF NPM PKN 7T5 7TK 7TO 7TS 7U9 H94 K9. 7X8 |
| ID | FETCH-LOGICAL-c506t-9298c5266bd300c03687aa436411eeca25502e82b9b41960076e03d30b721a823 |
| ISSN | 0002-9343 |
| IngestDate | Thu Oct 02 11:10:26 EDT 2025 Fri Oct 03 02:50:56 EDT 2025 Wed Feb 19 01:40:47 EST 2025 Wed Oct 01 05:27:20 EDT 2025 Thu Apr 24 23:08:52 EDT 2025 Fri Feb 23 02:26:12 EST 2024 Tue Oct 14 19:24:46 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Clinical prediction rule Community-acquired pneumonia |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c506t-9298c5266bd300c03687aa436411eeca25502e82b9b41960076e03d30b721a823 |
| Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-2 content type line 23 |
| PMID | 15808136 |
| PQID | 232331122 |
| PQPubID | 950 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_67702060 proquest_journals_232331122 pubmed_primary_15808136 crossref_citationtrail_10_1016_j_amjmed_2005_01_006 crossref_primary_10_1016_j_amjmed_2005_01_006 elsevier_sciencedirect_doi_10_1016_j_amjmed_2005_01_006 elsevier_clinicalkey_doi_10_1016_j_amjmed_2005_01_006 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2005-04-01 |
| PublicationDateYYYYMMDD | 2005-04-01 |
| PublicationDate_xml | – month: 04 year: 2005 text: 2005-04-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: New York |
| PublicationTitle | The American journal of medicine |
| PublicationTitleAlternate | Am J Med |
| PublicationYear | 2005 |
| Publisher | Elsevier Inc Elsevier Sequoia S.A |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier Sequoia S.A |
| References | McGee (bib21) 2002; 17 Adams, Hendershot, Marano (bib24) 1999; 10 Macfarlane, Boldy (bib18) 2004; 59 Hanley, McNeil (bib23) 1982; 143 Mandell, Bartlett, Dowell, File, Musher, Whitney (bib8) 2003; 37 Niederman, Mandell, Anzueto (bib3) 2001; 163 Yealy, Auble, Stone (bib19) 2004; 43 Arnold, Ramirez, McDonald, Xia (bib27) 2003; 124 Neill, Martin, Weir (bib14) 1996; 51 Lave, Lin, Hughes-Cromwick (bib25) 1999; 20 Metlay, Fine (bib7) 2003; 138 Marrie, Lau, Wheeler, Wong, Vandervoort, Feagan (bib11) 2000; 283 Fine, Smith, Carson (bib28) 1996; 275 Ewig, de Roux, Bauer (bib16) 2004; 59 (bib4) 2001; 56 (bib13) 1987; 62 Fine, Auble, Yealy (bib9) 1997; 336 Atlas, Benzer, Borowsky (bib10) 1998; 158 McNemar (bib22) 1947; 12 Bartlett, Dowell, Mandell, File, Musher, Fine (bib1) 2000; 31 Lim, van der Eerden, Laing (bib17) 2003; 58 Mandell, Marrie, Grossman, Chow, Hyland (bib2) 2000; 31 (bib5) 2001; 38 Palmer, Zhan, Elixhauser (bib12) 2000; 22 Halm, Teirstein (bib26) 2002; 347 Auble, Yealy, Fine (bib6) 1998; 12 Fine, Singer, Hanusa, Lave, Kapoor (bib20) 1993; 94 Lim, Macfarlane, Boswell (bib15) 2001; 56 Atlas (10.1016/j.amjmed.2005.01.006_bib10) 1998; 158 Ewig (10.1016/j.amjmed.2005.01.006_bib16) 2004; 59 Palmer (10.1016/j.amjmed.2005.01.006_bib12) 2000; 22 Fine (10.1016/j.amjmed.2005.01.006_bib20) 1993; 94 Niederman (10.1016/j.amjmed.2005.01.006_bib3) 2001; 163 Auble (10.1016/j.amjmed.2005.01.006_bib6) 1998; 12 Arnold (10.1016/j.amjmed.2005.01.006_bib27) 2003; 124 Fine (10.1016/j.amjmed.2005.01.006_bib9) 1997; 336 Neill (10.1016/j.amjmed.2005.01.006_bib14) 1996; 51 Lim (10.1016/j.amjmed.2005.01.006_bib15) 2001; 56 Yealy (10.1016/j.amjmed.2005.01.006_bib19) 2004; 43 Mandell (10.1016/j.amjmed.2005.01.006_bib8) 2003; 37 McGee (10.1016/j.amjmed.2005.01.006_bib21) 2002; 17 Hanley (10.1016/j.amjmed.2005.01.006_bib23) 1982; 143 Fine (10.1016/j.amjmed.2005.01.006_bib28) 1996; 275 (10.1016/j.amjmed.2005.01.006_bib4) 2001; 56 Marrie (10.1016/j.amjmed.2005.01.006_bib11) 2000; 283 Adams (10.1016/j.amjmed.2005.01.006_bib24) 1999; 10 Lim (10.1016/j.amjmed.2005.01.006_bib17) 2003; 58 Macfarlane (10.1016/j.amjmed.2005.01.006_bib18) 2004; 59 Metlay (10.1016/j.amjmed.2005.01.006_bib7) 2003; 138 Halm (10.1016/j.amjmed.2005.01.006_bib26) 2002; 347 (10.1016/j.amjmed.2005.01.006_bib5) 2001; 38 Mandell (10.1016/j.amjmed.2005.01.006_bib2) 2000; 31 Lave (10.1016/j.amjmed.2005.01.006_bib25) 1999; 20 (10.1016/j.amjmed.2005.01.006_bib13) 1987; 62 Bartlett (10.1016/j.amjmed.2005.01.006_bib1) 2000; 31 McNemar (10.1016/j.amjmed.2005.01.006_bib22) 1947; 12 |
| References_xml | – volume: 347 start-page: 2039 year: 2002 end-page: 2045 ident: bib26 article-title: Clinical practice publication-title: N Engl J Med – volume: 31 start-page: 383 year: 2000 end-page: 421 ident: bib2 article-title: Canadian guidelines for the initial management of community-acquired pneumonia publication-title: The Canadian Community-Acquired Pneumonia Working Group. – volume: 37 start-page: 1405 year: 2003 ident: bib8 article-title: Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults publication-title: Clin Infect Dis – volume: 12 start-page: 741 year: 1998 end-page: 759 ident: bib6 article-title: Assessing prognosis and selecting an initial site of care for adults with community-acquired pneumonia publication-title: Infect Dis Clin North Am – volume: 20 start-page: 189 year: 1999 end-page: 198 ident: bib25 article-title: The costs of treating patients with community-acquired pneumonia publication-title: Semin Respir Crit Care Med – volume: 22 start-page: 250 year: 2000 end-page: 264 ident: bib12 article-title: Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin publication-title: Clin Ther – volume: 58 start-page: 377 year: 2003 end-page: 382 ident: bib17 article-title: Defining community acquired pneumonia severity on presentation to hospital publication-title: Thorax – volume: 124 start-page: 121 year: 2003 end-page: 124 ident: bib27 article-title: Hospitalization for community-acquired pneumonia publication-title: Chest – volume: 51 start-page: 1010 year: 1996 end-page: 1016 ident: bib14 article-title: Community acquired pneumonia publication-title: Thorax – volume: 17 start-page: 646 year: 2002 end-page: 649 ident: bib21 article-title: Simplifying likelihood ratios publication-title: J Gen Intern Med – volume: 283 start-page: 749 year: 2000 end-page: 755 ident: bib11 article-title: A controlled trial of a critical pathway for treatment of community-acquired pneumonia publication-title: Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. – volume: 336 start-page: 243 year: 1997 end-page: 250 ident: bib9 article-title: A prediction rule to identify low-risk patients with community-acquired pneumonia publication-title: N Engl J Med – volume: 59 start-page: 364 year: 2004 end-page: 366 ident: bib18 article-title: 2004 update of BTS pneumonia guidelines publication-title: Thorax – volume: 138 start-page: 109 year: 2003 end-page: 118 ident: bib7 article-title: Testing strategies in the initial management of patients with community-acquired pneumonia publication-title: Ann Intern Med – volume: 158 start-page: 1350 year: 1998 end-page: 1356 ident: bib10 article-title: Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients publication-title: Arch Intern Med – volume: 10 start-page: 200 year: 1999 ident: bib24 article-title: Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics publication-title: Vital Health Stat. – volume: 12 start-page: 153 year: 1947 end-page: 157 ident: bib22 article-title: Note on the sampling error of the difference between correlated proportions or percentages publication-title: Psychometrika – volume: 31 start-page: 347 year: 2000 end-page: 382 ident: bib1 article-title: Practice guidelines for the management of community-acquired pneumonia in adults publication-title: Clin Infect Dis – volume: 94 start-page: 153 year: 1993 end-page: 159 ident: bib20 article-title: Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database publication-title: Am J Med – volume: 62 start-page: 195 year: 1987 end-page: 220 ident: bib13 article-title: Community-acquired pneumonia in adults in British hospitals in 1982–1983 publication-title: Q J Med – volume: 163 start-page: 1730 year: 2001 end-page: 1754 ident: bib3 article-title: Guidelines for the management of adults with community-acquired pneumonia publication-title: Am J Respir Crit Care Med – volume: 56 start-page: 296 year: 2001 end-page: 301 ident: bib15 article-title: Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital publication-title: Thorax – volume: 38 start-page: 107 year: 2001 end-page: 113 ident: bib5 article-title: Clinical policy for the management and risk stratification of community-acquired pneumonia in adults in the emergency department publication-title: Ann Emerg Med – volume: 56 year: 2001 ident: bib4 article-title: BTS Guidelines for the Management of Community Acquired Pneumonia in Adults publication-title: Thorax – volume: 143 start-page: 29 year: 1982 end-page: 36 ident: bib23 article-title: The meaning and use of the area under a receiver operating characteristic (ROC) curve publication-title: Radiology – volume: 59 start-page: 421 year: 2004 end-page: 427 ident: bib16 article-title: Validation of predictive rules and indices of severity for community acquired pneumonia publication-title: Thorax – volume: 43 start-page: 770 year: 2004 end-page: 782 ident: bib19 article-title: The emergency department community-acquired pneumonia trial publication-title: Ann Emerg Med – volume: 275 start-page: 134 year: 1996 end-page: 141 ident: bib28 article-title: Prognosis and outcomes of patients with community-acquired pneumonia publication-title: JAMA – volume: 59 start-page: 364 year: 2004 ident: 10.1016/j.amjmed.2005.01.006_bib18 article-title: 2004 update of BTS pneumonia guidelines publication-title: Thorax doi: 10.1136/thx.2004.024992 – volume: 283 start-page: 749 year: 2000 ident: 10.1016/j.amjmed.2005.01.006_bib11 article-title: A controlled trial of a critical pathway for treatment of community-acquired pneumonia publication-title: Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA – volume: 12 start-page: 741 year: 1998 ident: 10.1016/j.amjmed.2005.01.006_bib6 article-title: Assessing prognosis and selecting an initial site of care for adults with community-acquired pneumonia publication-title: Infect Dis Clin North Am doi: 10.1016/S0891-5520(05)70208-7 – volume: 22 start-page: 250 year: 2000 ident: 10.1016/j.amjmed.2005.01.006_bib12 article-title: Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin publication-title: Clin Ther doi: 10.1016/S0149-2918(00)88483-0 – volume: 31 start-page: 347 year: 2000 ident: 10.1016/j.amjmed.2005.01.006_bib1 article-title: Practice guidelines for the management of community-acquired pneumonia in adults publication-title: Clin Infect Dis doi: 10.1086/313954 – volume: 59 start-page: 421 year: 2004 ident: 10.1016/j.amjmed.2005.01.006_bib16 article-title: Validation of predictive rules and indices of severity for community acquired pneumonia publication-title: Thorax doi: 10.1136/thx.2003.008110 – volume: 158 start-page: 1350 year: 1998 ident: 10.1016/j.amjmed.2005.01.006_bib10 article-title: Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients publication-title: Arch Intern Med doi: 10.1001/archinte.158.12.1350 – volume: 62 start-page: 195 year: 1987 ident: 10.1016/j.amjmed.2005.01.006_bib13 article-title: Community-acquired pneumonia in adults in British hospitals in 1982–1983 publication-title: Q J Med doi: 10.1093/oxfordjournals.qjmed.a068093 – volume: 94 start-page: 153 year: 1993 ident: 10.1016/j.amjmed.2005.01.006_bib20 article-title: Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database publication-title: Am J Med doi: 10.1016/0002-9343(93)90177-Q – volume: 38 start-page: 107 year: 2001 ident: 10.1016/j.amjmed.2005.01.006_bib5 article-title: Clinical policy for the management and risk stratification of community-acquired pneumonia in adults in the emergency department publication-title: Ann Emerg Med doi: 10.1067/mem.2001.115880 – volume: 275 start-page: 134 year: 1996 ident: 10.1016/j.amjmed.2005.01.006_bib28 article-title: Prognosis and outcomes of patients with community-acquired pneumonia publication-title: JAMA doi: 10.1001/jama.1996.03530260048030 – volume: 336 start-page: 243 year: 1997 ident: 10.1016/j.amjmed.2005.01.006_bib9 article-title: A prediction rule to identify low-risk patients with community-acquired pneumonia publication-title: N Engl J Med doi: 10.1056/NEJM199701233360402 – volume: 163 start-page: 1730 year: 2001 ident: 10.1016/j.amjmed.2005.01.006_bib3 article-title: Guidelines for the management of adults with community-acquired pneumonia publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.163.7.at1010 – volume: 51 start-page: 1010 year: 1996 ident: 10.1016/j.amjmed.2005.01.006_bib14 article-title: Community acquired pneumonia publication-title: Thorax doi: 10.1136/thx.51.10.1010 – volume: 20 start-page: 189 year: 1999 ident: 10.1016/j.amjmed.2005.01.006_bib25 article-title: The costs of treating patients with community-acquired pneumonia publication-title: Semin Respir Crit Care Med doi: 10.1055/s-2007-1021315 – volume: 56 issue: suppl 4 year: 2001 ident: 10.1016/j.amjmed.2005.01.006_bib4 article-title: BTS Guidelines for the Management of Community Acquired Pneumonia in Adults publication-title: Thorax – volume: 138 start-page: 109 year: 2003 ident: 10.1016/j.amjmed.2005.01.006_bib7 article-title: Testing strategies in the initial management of patients with community-acquired pneumonia publication-title: Ann Intern Med doi: 10.7326/0003-4819-138-2-200301210-00012 – volume: 58 start-page: 377 year: 2003 ident: 10.1016/j.amjmed.2005.01.006_bib17 article-title: Defining community acquired pneumonia severity on presentation to hospital publication-title: Thorax doi: 10.1136/thorax.58.5.377 – volume: 347 start-page: 2039 year: 2002 ident: 10.1016/j.amjmed.2005.01.006_bib26 article-title: Clinical practice publication-title: N Engl J Med doi: 10.1056/NEJMcp020499 – volume: 12 start-page: 153 year: 1947 ident: 10.1016/j.amjmed.2005.01.006_bib22 article-title: Note on the sampling error of the difference between correlated proportions or percentages publication-title: Psychometrika doi: 10.1007/BF02295996 – volume: 143 start-page: 29 year: 1982 ident: 10.1016/j.amjmed.2005.01.006_bib23 article-title: The meaning and use of the area under a receiver operating characteristic (ROC) curve publication-title: Radiology doi: 10.1148/radiology.143.1.7063747 – volume: 56 start-page: 296 year: 2001 ident: 10.1016/j.amjmed.2005.01.006_bib15 article-title: Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital publication-title: Thorax doi: 10.1136/thorax.56.4.296 – volume: 17 start-page: 646 year: 2002 ident: 10.1016/j.amjmed.2005.01.006_bib21 article-title: Simplifying likelihood ratios publication-title: J Gen Intern Med doi: 10.1046/j.1525-1497.2002.10750.x – volume: 31 start-page: 383 year: 2000 ident: 10.1016/j.amjmed.2005.01.006_bib2 article-title: Canadian guidelines for the initial management of community-acquired pneumonia publication-title: The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis – volume: 37 start-page: 1405 year: 2003 ident: 10.1016/j.amjmed.2005.01.006_bib8 article-title: Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults publication-title: Clin Infect Dis doi: 10.1086/380488 – volume: 10 start-page: 200 year: 1999 ident: 10.1016/j.amjmed.2005.01.006_bib24 article-title: Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics publication-title: Vital Health Stat. – volume: 43 start-page: 770 year: 2004 ident: 10.1016/j.amjmed.2005.01.006_bib19 article-title: The emergency department community-acquired pneumonia trial publication-title: Ann Emerg Med doi: 10.1016/j.annemergmed.2003.09.013 – volume: 124 start-page: 121 year: 2003 ident: 10.1016/j.amjmed.2005.01.006_bib27 article-title: Hospitalization for community-acquired pneumonia publication-title: Chest doi: 10.1378/chest.124.1.121 |
| SSID | ssj0000956 |
| Score | 2.3261528 |
| Snippet | We assessed the performance of 3 validated prognostic rules in predicting 30-day mortality in community-acquired pneumonia: the 20 variable Pneumonia Severity... Purpose: We assessed the performance of 3 validated prognostic rules in predicting 30-day mortality in community-acquired pneumonia: the 20 variable Pneumonia... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 384 |
| SubjectTerms | Aged Blood Pressure Blood Urea Nitrogen Clinical prediction rule Community-Acquired Infections - mortality Community-acquired pneumonia Comparative analysis Confusion Female Humans Male Middle Aged Pneumonia Pneumonia - mortality Prognosis Prospective Studies ROC Curve Sensitivity and Specificity Severity of Illness Index Survival analysis |
| Title | Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0002934305000070 https://dx.doi.org/10.1016/j.amjmed.2005.01.006 https://www.ncbi.nlm.nih.gov/pubmed/15808136 https://www.proquest.com/docview/232331122 https://www.proquest.com/docview/67702060 |
| Volume | 118 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1555-7162 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000956 issn: 0002-9343 databaseCode: AKRWK dateStart: 19460701 isFulltext: true providerName: Library Specific Holdings |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqTkK8IO6UcfEDb1UqJ871sYKhiakIoU7sLbI9R6TqEtQ2D-PP8Fc5vsQOK2MbL1EVx2nd8_ncfC4IvUuiOCVVyIKKRCKII5YGBQiCIAc8CZLmvCpUgvPic3p8Gn86S85Go1-DqKVux2fi51_zSv6HqnAP6KqyZO9AWfdSuAGfgb5wBQrD9VY0_rJp-0xJG0xuGwqq9jtSTuG7amXR61IA57XpCr7p1lIXYdCxWU2rKpKYYHSVKbK7DJhQ0cFqUiM7WEvNhhrs0qeiNMO6E1cP6efdSlrH7AdgaO1FvfFD3AQxm-ik6dHMe26Z6XxtXNbThRvRRcNNKPh2fdlM57M__BXJIMzF8-CCmuJMjgd7Juw9DJqjUtNBzgpnahrn7fF944JYzdjFCpZrXWWhCtrzcq4_278i_lxQYh_vtirNW1SHzqQkYalLuh9EIDbIGB3MT75-O_HCvtANgt2i-uxMHUK4_2uu036us260lrN8iB5Y8wTPDdYeoZFsHqN7C0vbJ-j7AHLYQw63FdaQww5y2EMOa8hhgBx2kMN1g_chhx3knqLTj0fL98eBbdYRiISkuwDU7FwkoO7xc0qIAMUozxiLaRqHoZSCgelKIplHvOAxcH11AiwJhWd5FoUsj-gzNG4ASS8QLgQvCklIBap6zBOmfBCFCDOW8iyHN04Q7f_EUthK9qqhyrr8FwknKHCzfphKLjc8n_T0KfssZZCrJUDuhnmZm2e1WKOd3mLmYQ-D0u7fbQkWD6VgFEUT9NaNgghQ53qskW23LdMsA6MvJRP03GDHry9RjXVo-vKOaz9E9_3WfYXGu00nX4PyveNv7Ab4DYYv3GQ |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prospective+comparison+of+three+validated+prediction+rules+for+prognosis+in+community-acquired+pneumonia&rft.jtitle=The+American+journal+of+medicine&rft.au=Aujesky%2C+Drahomir&rft.au=Auble%2C+Thomas+E.&rft.au=Yealy%2C+Donald+M.&rft.au=Stone%2C+Roslyn+A.&rft.date=2005-04-01&rft.issn=0002-9343&rft.volume=118&rft.issue=4&rft.spage=384&rft.epage=392&rft_id=info:doi/10.1016%2Fj.amjmed.2005.01.006&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_amjmed_2005_01_006 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9343&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9343&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9343&client=summon |